Appia Bio names new director and new chief scientific officer
10 August 2022 -

Appia Bio, Inc., a US-based preclinical-stage biotechnology company, announced on Tuesday that it has named Margo Roberts, PhD as its new director and Jason Damiano, PhD as its new chief scientific officer (CSO).

Dr Roberts has served as CSO of Kite Pharma, Inc. and Lyell Immunopharma. She has served as principal scientist and director of immune and cell therapy at Cell Genesys. She continues to serve on the company's Scientific Advisory Board.

Dr Damiano has served as vice president of biology at UNITY Biotechnology. He has served as the director of therapeutic antibody discovery and translational medicine at Achaogen and director of biology at Igenica Biotherapeutics, a senior research investigator in Oncology Biotherapeutics at the Novartis Institutes for Biomedical Research, and a scientist at Chiron.